drugset / Trial / NCT00027053

Trazodone for Sleep Disturbance in Early Alcohol Recovery

NCT00027053

RandomizedParallel-groupDouble-blindTreatment

Summary

This study is a randomized, double-blind clinical trial comparing trazodone (Desyrel) and placebo among sleep-disturbed, alcohol-dependent individuals shortly after discharge from an inpatient detoxification program. Subjects will undergo a baseline assessment and random assignment to trazodone or identical placebo for 12 weeks. All persons completing the alcohol detoxification at Stanley Street Treatment and Resources (SSTAR) will be screened. (SSTAR of Rhode Island provides detoxification services to non/underinsured persons of Rhode Island.)

Timeline

Start
2002-06
Primary completion
2006-01
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Trazodone Small molecule 50 mg
Subject Trazodone Small molecule 150 mg

Indications